Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Microbiology Susceptibility Testing
  4. Susceptibility Testing Systems
  5. 22778090

Liofilchem™ ComASP Ceftolozane-tazobactam
SDP

Catalog No. 22778090
Click to view available options
Quantity:
4 Systems (panels)
Non-hazardous according to current legislation but fall within the specific field of application where a safety data sheet must be supplied because they can cause phenomena of sensitisation in sensitive subjects if they come into contact with the skin.
Non-hazardous according to current legislation but fall within the specific field of application where a safety data sheet must be supplied because they can cause phenomena of sensitisation in sensitive subjects if they come into contact with the skin.

Description

The system is used to perform the broth microdilution (BMD) method for the antimicrobial susceptibility testing of ceftolozane-tazobactam as recommended by international standards (i.e. CLSI, EUCAST, ISO) but in a simpler and less time-consuming way

  • 4 Systems (panels) of ComASP C/T (panels individually packed in foil with silica gel desiccant
  • 8 Tubes of Mueller Hinton II Broth (3.6 mL)
  • Sealing Film
  • Instructions Sheet and Test Results Form

Specifications

Antimicrobial Agents Ceftolozane-tazobactam
Concentration 0.008 to 128 μg/mL
Content And Storage Store ComASP™ C/T at 2°C to 8°C in the original packaging. Once an envelope is opened the panel should be used within 7 days. Keep away from direct sunlight and direct heat
Product Type Panel
Sterility Non-sterile
Test Type Media Testing
Quantity 4 Systems (panels)
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.